Ectopic expression of HLA-DO in mouse dendritic cells diminishes MHC class II antigen presentation

Journal of Immunology

Volumn 173, Issue 3, 2004, Pages 1549-1560

  Fallas, Jennifer L ^a   Tobin, Helen M ^b   Lou, Olivia ^a   Guo, Donglin ^b,c   Sant'Angelo, Derek B ^a,b   Denzin, Lisa K ^a,b  

^a Weill Cornell Graduate School of Biomedical Sciences   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c Cytokinetics Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DO ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANIMAL CELL; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ARTICLE; DENDRITIC CELL; EMBRYO; GENE CONTROL; HYBRIDOMA; IMMUNOMODULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; TRANSGENIC MOUSE;

EID: 3242772752     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.173.3.1549     Document Type: Article

References (52)

1. Wolf, P. R., and H. L. Ploegh. 1995. How MHC class II molecules acquire peptide cargo: biosynthesis and trafficking through the endocytic pathway. Annu. Rev. Cell. Dev. Biol. 11:267.
2. Pieters, J. 1997. MHC class II restricted antigen presentation. Curr. Opin. Immunol. 9:89.
3. Busch, R., R. C. Doebele, N. S. Patil, A. Pashine, and E. D. Mellins. 2000. Accessory molecules for MHC class II peptide loading. Curr. Opin. Immunol. 12:99.
4. Jensen, P. E., D. A. Weber, W. P. Thayer, L. E. Westerman, and C. T. Dao. 1999. Peptide exchange in MHC molecules. Immunol. Rev. 172:229.
5. Alfonso, C., and L. Karlsson. 2000. Nonclassical MHC class II molecules. Annu. Rev. Immunol. 18:113.
6. Liljedahl, M., T. Kuwana, W. P. Fung-Leung, M. R. Jackson, P. A. Peterson, and L. Karlsson. 1996. HLA-DO is a lysosomal resident which requires association with HLA-DM for efficient intracellular transport. EMBO J. 15:4817.
7. Denzin, L. K., D. B. Sant'Angelo, C. Hammond, M. J. Surman, and P. Cresswell. 1997. Negative regulation by HLA-DO of MHC class II-restricted antigen processing. Science 278:106.
8. van Ham, S. M., E. P. Tjin, B. F. Lillemeier, U. Gruneberg, K. E. van Meijgaarden, L. Pastoors, D. Verwoerd, A. Tulp, B. Canas, D. Rahman, et al. 1997. HLA-DO is a negative modulator of HLA-DM-mediated MHC class II peptide loading. Curr. Biol 7:950.
9. Alfonso, C., G. S. Williams, J. O. Han, J. A. Westberg, O. Winqvist, and L. Karlsson. 2003. Analysis of H2-O influence on antigen presentation by B cells. J. Immunol 171:2331.
10. Alfonso, C., G. S. Williams, and L. Karlsson. 2003. H2-O influence on antigen presentation in H2-E-expressing mice. Eur. J. Immunol. 33:2014.
11. Brocke, P., E. Armandola, N. Garbi, and G. J. Hammerling. 2003. Downmodulation of antigen presentation by H2-O in B cell lines and primary B lymphocytes. Eur. J. Immunol. 33:411.
12. Liljedahl, M., O. Winqvist, C. D. Surh, P. Wong, K. Ngo, L. Teyton, P. A. Peterson, A. Brunmark, A. Y. Rudensky, W. P. Fung-Leung, and L. Karlsson. 1998. Altered antigen presentation in mice lacking H2-O. Immunity 8:233.
13. van Ham, M., M. van Lith, B. Lillemeier, E. Tjin, U. Gruneberg, D. Rahman, L. Pastoors, K. van Meijgaarden, C. Roucard, J. Trowsdale, et al. 2000. Modulation of the major histocompatibility complex class II-associated peptide repertoire by human histocompatibility leukocyte antigen (HLA)-DO. J. Exp. Med. 191:1127.
14. Glazier, K. S., S. B. Hake, H. M. Tobin, A. Chadburn, E. J. Schattner, and L. K. Denzin. 2002. Germinal center B cells regulate their capability to present antigen by modulation of HLA-DO. J. Exp. Med. 195:1063.
15. Chen, X., O. Laur, T. Kambayashi, S. Li, R. A. Bray, D. A. Weber, L. Karlsson, and P. E. Jensen: 2002. Regulated expression of human histocompatibility leukocyte antigen (HLA)-DO during antigen-dependent and antigen-independent phases of B cell development. J. Exp. Med. 195:1053.
16. Kropshofer, H., A. B. Vogt, C. Thery, E. A. Armandola, B. C. Li, G. Moldenhauer, S. Amigorena, and G. J. Hammerling. 1998. A role for HLA-DO as a co-chaperone of HLA-DM in peptide loading of MHC class II molecules. EMBO J. 17:2971.
17. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392:245.
18. Pierre, P., S. J. Turley, E. Gatti, M. Hull, J. Meltzer, A. Mirza, K. Inaba, R. M. Steinman, and I. Mellman. 1997. Developmental regulation of MHC class II transport in mouse dendritic cells. Nature 388:787.
19. Watts, C., and S. Amigorena. 2000. Antigen traffic pathways in dendritic cells. Traffic 1:312.
20. Sant'Angelo, D. B., and C. A. Janeway, Jr. 2002. Negative selection of thymocytes expressing the D10 TCR. Proc. Natl. Acad. Sci. USA 99:6931.
21. Brocker, T., M. Riedinger, and K. Karjalainen. 1997. Targeted expression of major histocompatibility complex (MHC) class II molecules demonstrates that dendritic cells can induce negative but not positive selection of thymocytes in vivo. J. Exp. Med. 185:541.
22. Denzin, L. K., and P. Cresswell. 1995. HLA-DM induces CLIP dissociation from MHC class II αβ dimers and facilitates peptide loading. Cell 82:155.
23. Zhong, G., C. Reis e Sousa, and R. N. Germain. 1997. Production, specificity, and functionality of monoclonal antibodies to specific peptide-major histocompatibility complex class II complexes formed by processing of exogenous protein. Proc. Natl. Acad. Sci. USA 94:13856.
24. Hammond, C., L. K. Denzin, M. Pan, J. M. Griffith, H. J. Geuze, and P. Cresswell. 1998. The tetraspan protein CD82 is a resident of MHC class II compartments where it associates with HLA-DR, -DM, and -DO molecules. J. Immunol. 161:3282.
25. Murphy, D. B., S. Rath, E. Pizzo, A. Y. Rudensky, A. George, J. K. Larson, and C. A. Janeway, Jr. 1992. Monoclonal antibody detection of a major self peptide: MHC class II complex. J. Immunol. 148:3483.
26. Inaba, K., M. Inaba, N. Romani, H. Aya, M. Deguchi, S. Ikehara, S. Muramatsu, and R. M. Steinman. 1992. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 176:1693.
27. Inaba, K., S. Turley, T. Iyoda, F. Yamaide, S. Shimoyama, C. Reis e Sousa, R. N. Germain, I. Mellman, and R. M. Steinman. 2000. The formation of immunogenic major histocompatibility complex class II-peptide ligands in lysosomal compartments of dendritic cells is regulated by inflammatory stimuli. J. Exp. Med. 191:927.
28. Porath, J., K. Asperberg, H. Drevin, and R. Axen. 1973. Preparation of cyanogen bromide-activated agarose gels. J. Chromatogr. 86:53.
29. Sant'Angelo, D. B., P. Cresswell, C. A. Janeway, Jr., and L. K. Denzin. 2001. Maintenance of TCR clonality in T cells expressing genes for two TCR heterodimers. Proc. Natl. Acad. Sci. USA 98:6824.
30. Gordon, K. M., L. Duckett, B. Daul, and H. T. Petrie. 2003. A simple method for detecting up to five immunofluorescent parameters together with DNA staining for cell cycle or viability on a benchtop flow cytometer. J. Immunol. Methods 275:113.
31. Grubin, C. E., S. Kovats, P. deRoos, and A. Y. Rudensky. 1997. Deficient positive selection of CD4 T cells in mice displaying altered repertoires of MHC class II-bound self-peptides. Immunity 7:197.
32. Dongre, A. R., S. Kovats, P. deRoos, A. L. McCormack, T. Nakagawa, V. Paharkova-Vatchkova, J. Eng, H. Caldwell, J. R. Yates, III, and A. Y. Rudensky. 2001. In vivo MHC class II presentation of cytosolic proteins revealed by rapid automated tandem mass spectrometry and functional analyses. Eur. J. Immunol. 31:1485.
33. Allen, P. M., and E. R. Unanue. 1984. Differential requirements for antigen processing by macrophages for lysozyme-specific T cell hybridomas. J. Immunol. 132:1077.
34. + T cells in transgenic mice expressing a class II MHC-restricted antigen receptor. Nature 341:746.
35. Sant'Angelo, D. B., G. Waterbury, P. Preston-Hurlburt, S. T. Yoon, R. Medzhitov, S. C. Hong, and C. A. Janeway, Jr. 1996. The specificity and orientation of a TCR to its peptide-MHC class II ligands. Immunity 4:367.
36. Denzin, L. K., N. F. Robbins, C. Carboy-Newcomb, and P. Cresswell. 1994. Assembly and intracellular transport of HLA-DM and correction of the class II antigen-processing defect in T2 cells. Immunity 1:595.
37. Chalouni, C., J. Banchereau, A. B. Vogt, V. Pascual, and J. Davoust. 2003. Human germinal center B cells differ from naive and memory B cells by their aggregated MHC class II-rich compartments lacking HLA-DO. Int. Immunol. 15:457.
38. Cella, M., A. Engering, V. Pinet, J. Pieters, and A. Lanzavecchia. 1997. Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells. Nature 388:782.
39. Mellman, I., and R. M. Steinman. 2001. Dendritic cells: specialized and regulated antigen processing machines. Cell 106:255.
40. Turley, S. J., K. Inaba, W. S. Garrett, M. Ebersold, J. Unternaehrer, R. M. Steinman, and I. Mellman. 2000. Transport of peptide-MHC class II complexes in developing dendritic cells. Science 288:522.
41. Rudensky, A., S. Rath, P. Preston-Hurlburt, D. B. Murphy, and C. A. Janeway, Jr. 1991. On the complexity of self. Nature 353:660.
42. Fung-Leung, W. P., C. D. Surh, M. Liljedahl, J. Pang, D. Leturcq, P. A. Peterson, S. R. Webb, and L. Karlsson. 1996. Antigen presentation and T cell development in H2-M-deficient mice. Science 271:1278.
43. Koonce, C. H., G. Wutz, E. J. Robertson, A. B. Vogt, H. Kropshofer, and E. K. Bikoff. 2003. DM loss in k haplotype mice reveals isotype-specific chaperone requirements. J. Immunol. 170:3751.
44. Martin, W. D., G. G. Hicks, S. K. Mendiratta, H. I. Leva, H. E. Ruley, and L. Van Kaer. 1996. H2-M mutant mice are defective in the peptide loading of class II molecules, antigen presentation, and T cell repertoire selection. Cell 84:543.
45. Qi, L., and S. Ostrand-Rosenberg. 2001. H2-O inhibits presentation of bacterial superantigens, but not endogenous self antigens. J. Immunol. 167:1371.
46. Kovats, S., C. E. Grubin, S. Eastman, P. deRoos, A. Dongre, L. Van Kaer, and A. Y. Rudensky. 1998. Invariant chain-independent function of H-2M in the formation of endogenous peptide-major histocompatibility complex class II complexes in vivo. J. Exp. Med. 187:245.
47. Angelisova, P., I. Hilgert, and V. Horejsi. 1994. Association of four antigens of the tetraspans family (CD37, CD53, TAPA-1, and R2/C33) with MHC class II glycoproteins. Immunogenetics 39:249.
48. Imai, T., M. Kakizaki, M. Nishimura, and O. Yoshie. 1995. Molecular analyses of the association of CD4 with two members of the transmembrane 4 superfamily, CD81 and CD82. J. Immunol. 155:1229.
49. Lagaudriere-Gesbert, C., S. Lebel-Binay, E. Wiertz, H. L. Ploegh, D. Fradelizi, and H. Conjeaud. 1997. The tetraspanin protein CD82 associates with both free HLA class I heavy chain and heterodimeric β2-microglobulin complexes. J. Immunol. 158:2790.
50. 1 (CD49d/CD29). J. Immunol. 157:2039.
51. Rubinstein, E., F. Le Naour, C. Lagaudriere-Gesbert, M. Billard, H. Conjeaud, and C. Boucheix. 1996. CD9, CD63, CD81, and CD82 are components of a surface tetraspan network connected to HLA-DR and VLA integrals. Eur. J. Immunol. 26:2657.
52. Szollosi, J., V. Horejsi, L. Bene, P. Angelisova, and S. Damjanovich. 1996. Supramolecular complexes of MHC class I, MHC class II, CD20, and tetraspan molecules (CD53, CD81, and CD82) at the surface of a B cell line JY. J. Immunol. 157:2939.